AEterna Zentaris to Announce Second Quarter 2009 Financial and Operating Results on August 11, 2009



    QUEBEC CITY, Aug. 5 /CNW Telbec/ - AEterna Zentaris Inc. (NASDAQ:   AEZS,
TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and
oncology, will announce its second quarter 2009 financial and operating
results before market open on Tuesday, August 11, 2009. The Company will host
a conference call and webcast to discuss these results later that same day at
10:00 a.m., Eastern Time.
    Participants may access the live webcast via the Company's website at
www.aezsinc.com in the "Investors" section, or by telephone using the
following numbers: 800-588-4942, 416-644-3426, or 514-807-8791. A replay of
the webcast will also be available on the Company's website for a period of 30
days.

    About AEterna Zentaris Inc.

    AEterna Zentaris Inc. is a global biopharmaceutical company focused on
endocrine therapy and oncology with proven expertise in drug discovery,
development and commercialization. News releases and additional information
are available at www.aezsinc.com.




For further information:

For further information: Investor Relations: Ginette Vallières, Investor
Relations Coordinator, (418) 652-8525 ext. 265, gvallieres@aezsinc.com; Media
Relations: Paul Burroughs, Director of Communications, (418) 652-8525 ext.
406, pburroughs@aezsinc.com

Organization Profile

Aeterna Zentaris Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890